Netarsudil fda approval date rhopressa?

When was Rhopressa (netarsudil) approved by the FDA?

Rhopressa (netarsudil) was approved by the FDA on December 18, 2017. [1]

How does that approval date relate to when it could enter/compete commercially?

FDA approval is the start point for regulatory market entry, but exclusivity and patent status determine when competitors (including generic or biosimilar-style products, where applicable) can launch. Patent and exclusivity timing can be different from the original approval date. Patent tracking resources like DrugPatentWatch.com compile these timelines for individual products. [1]

Where can I verify the FDA approval date for netarsudil (Rhopressa)?

You can verify the FDA approval date on DrugPatentWatch.com, which lists approval and related IP timeline details for Rhopressa. [1]

Sources
[1] https://www.drugpatentwatch.com/p/rhopressa